🚨 Final Call for the £7.5m (~$10m) Longitude Prize on ALS. Don’t miss your chance to make a real difference for those living with #ALS (the most common form of #MND). Submit your application by 15:00 GMT (10:00 AM EST) tomorrow! Apply here: bit.ly/4nyp6nq

We urgently need new treatments for MND and this analysis from the Longitude Prize on ALS demonstrates there's an economic model for developing them. We hope this helps to boost the number of companies globally working towards a world free of MND 💙💛

Longitude Prize on ALS@longitudeprize.bsky.social · 9mo ago

@ohenews.bsky.social estimates that eradicating ALS could deliver $143B+ in value over 10 years. The potential global value is huge. #ALS and #MND remain underfunded and breakthroughs are urgently needed. Full report: lnkd.in/e3-DMaiB Learn more about the Prize bit.ly/4nyp6nq

⏰1 week to go! Entries to the £7.5M (~$10M) Longitude Prize on ALS are closing next week – submit your application before Wednesday 3rd December 2025. Your expertise could make the difference. 🔗Learn more and apply today: bit.ly/4nyp6nq

@ohenews.bsky.social estimates that eradicating ALS could deliver $143B+ in value over 10 years. The potential global value is huge. #ALS and #MND remain underfunded and breakthroughs are urgently needed. Full report: lnkd.in/e3-DMaiB Learn more about the Prize bit.ly/4nyp6nq

🚨 Only 2 weeks left to apply! The £7.5M (~$10M) Longitude Prize on ALS is closing soon – submit your application before 3 December 2025 and don’t miss your chance to make a real difference. 🔗 To learn more about the Prize, click here: bit.ly/4nyp6nq

New analysis puts a multi-billion-dollar value on progress as Japan opens new scientific pathways for ALS discovery. longevity.technology/news/the-eco... #longevity #ALS #biotech #neuroscience #healthinnovation #drugdevelopment #futureofmedicine

There's 1 month left to apply for the £7.5m (~$10m) Longitude Prize on ALS, start your application today - bit.ly/4nyp6nq #AIforGood #ALS #MND #Neuroscience

We recently spoke to Paul Wright, Head of MND & Rare Dementias at @lifearc.bsky.social. Paul details LifeArc's main ambitions, how the organisation is working to make MND treatable and ultimately preventable, and why they joined the Prize. 🧬 Read here: bit.ly/3X1Ow1M

We had the pleasure of catching up with Dr Brian Dickie MBE (@bd365.bsky.social), Chief Scientist at the @mndassoc.bsky.social, the principal funder of the £7.5M Longitude Prize on ALS. 📖 Read the full Q&A here: bit.ly/3KTi1Ap

Join us at the #ALSTDI Summit in Boston, MA tomorrow to learn more about how we're bringing #AI and unprecedented data to the fight against #ALS, the most common form of motor neurone disease ( #MND). #LouGehrig #AIforGood #DrugDiscovery #HealthInnovation #Neurodegeneration

ALS Therapy Development Institute@alstdi.bsky.social · 10mo ago

Summit day is almost here! 🙌 Join us this Friday for the ALS TDI Summit — a free conference sharing the latest breakthroughs in ALS research. There’s still time to register to attend virtually 🌍 👉 fundraise.als.net/alssummit

⏰ 2 months to go until applications close for the £7.5 million Longitude Prize on ALS. You could help transform treatment for neurodegenerative diseases like hashtag #ALS, the most common form of motor neurone disease ( #MND ). Learn more: bit.ly/4mlzSg5

Join us at the #ASHG25 Annual Meeting in Boston, starting today! Visit us at Booth 46, we’d love to meet you and discuss how the ~$10M Longitude Prize on ALS is harnessing #AI to transform the future of neurodegenerative disease treatment. @challengeworks.bsky.social @geneticssociety.bsky.social

⏰ 2 months to go until applications close for the £7.5 million Longitude Prize on ALS. You could help transform treatment for neurodegenerative diseases like hashtag #ALS, the most common form of motor neurone disease ( #MND ). Learn more: bit.ly/4mlzSg5

How the Longitude Prize on ALS Can Transform Lives with AI Innovations The Longitude Prize on ALS represents a pivotal moment in addressing one of the most challenging neurodegenerative diseases: amyotrophic lateral sclerosis (ALS). Caroline Purslow, Head of Health at Challenge Works, highlights…

How the Longitude Prize on ALS Can Transform Lives with AI Innovations

The Longitude Prize on ALS represents a pivotal moment in addressing one of the most challenging neurodegenerative diseases: amyotrophic lateral sclerosis (ALS). Caroline Purslow, Head of Health at Challenge Works, highlights the deeply personal story behind this initiative. The hope is to harness the power of artificial intelligence (AI) to revolutionize treatment and care for those battling this disease. A Personal Journey…

therealpreneur.com

🌍 We're back on the road in October! Join us at one of the below events and learn more about how the Prize works, what's on offer for participants, and how you can get involved. We'd love to meet you! 🔗See more bit.ly/4nkXHWS

🧠 We recently spoke with The 10,000 Brains Project, one of our US-based funders, about why they’re backing the Longitude Prize on ALS and the opportunities for innovators worldwide when different expertise work together. 📖 Read the full interview here: bit.ly/3KhpFEa

We're hosting Harnessing AI for ALS: Longitude Prize on ALS networking event, in London. Make sure to attend on 14 October. Spaces are limited so please register before 20 September. www.linkedin.com/events/harne...

International funding is vital to the success of the #LongitudePrizeonALS and we're proud to be supported by @answerals.bsky.social, one of 9 funders of the Prize. The £7.5m ($10m USD) Prize is driving change for those living with #ALS all over the world. Learn more bit.ly/3KbfXmV

📰 @amalia-papa.bsky.social, Data Programme Lead at @challengeworks.bsky.social writes how AI and big data in healthcare has advanced over the past decade By combining new ALS datasets with powerful #AI, we're transforming drug discovery for those affected by #ALS and #MND Read more bit.ly/46bQHpc

Delivering on a decade of ALS data – the role of AI in drug discovery | The AI Journal

The use of artificial intelligence and big data in healthcare has advanced at remarkable speed over the past decade, rapidly reshaping how we diagnose, treat,

bit.ly

The Prize would not be possible without the support of our international funders. We spoke with Colin Reid, trustee at the Alan Davidson Foundation, about why they are backing the £7.5M global challenge to transform drug discovery for #ALS 🔗 Read the full Q&A: bit.ly/4glrUm2

Tris Dyson, managing director of Challenge Works, discusses his diagnosis of ALS, the case for using a prize to spur innovation, and the potential for leveraging AI to find treatments for the disease. @globalgenes.bsky.social #RARECast globalgenes.org/raredaily/us...

Using AI Open Innovation to Tackle ALS

Tris Dyson, managing director of Challenge Works, about his diagnosis of ALS, the case for using a prize to spur innovation, and the potential for leveraging AI to find treatments for the disease.

globalgenes.org

Applications are open for the £7.5M @longitudeprize.bsky.social on ALS 📣 We're proud to support this global challenge, accelerating AI-driven treatment discovery for one of the most complex diseases in medicine. Learn more about the prize and how to get involved ⤵️

Longitude Prize on ALS@longitudeprize.bsky.social · last yr.

🧠 The #LongitudePrizeOnALS is now live! This £7.5M global challenge invites innovators across #biotech, #AI, #data science & beyond to help accelerate #ALS treatment discovery. Join us in bringing AI to the fight against ALS. Learn more: bit.ly/4kD3tSh #LPALS #MND

🚨 1 week to go! Curious about the Longitude Prize on ALS or planning to enter? You won't want to miss this. Be the first to explore the data powering the Prize with our partners and register now👇 bit.ly/477W1ea

🌍 Be part of the global effort to tackle #ALS. The £7.5m (~$10m) #LongitudePrizeOnALS is searching for innovators in #AI, #data, #biotech, and #neurology. 🧠 Meet the teams already registered, and find out how you can partner with them below. 🔗https://bit.ly/4mdHxxX

🧠 The @ukmndri.bsky.social is an #MND powerhouse, accelerating progress towards new treatments and, ultimately, a cure. Read their article about how the #LongitudePrizeOnALS could be a game-changer for drug discovery in neurodegenerative diseases. 🔗 bit.ly/40Tmmsh @ammaralchalabi.bsky.social

Longitude Prize launched to accelerate AI-driven drug discovery

A new international challenge prize has been launched to transform drug discovery for ALS, the most common form of MND through AI.

ukmndri.org

How can #AI transform #ALS drug discovery? @carolinepurslow.bsky.social from @challengeworks.bsky.social explains why now is the moment for the £7.5M Longitude Prize on ALS — and how AI could help outpace one of medicine’s toughest diseases. 🧠Read more: bit.ly/3IMpGPX #ALS #MND #AIforGood

We're proud to partner with @mndoddie5.bsky.social, a driving force in the fight against #MND & #ALS. As a funder of the #LongitudePrizeOnALS, they're supporting bold new ideas to transform #DrugDiscovery for one of medicine's toughest challenges. 🔗Learn more: bit.ly/457a8zo

💡 @trisdyson.bsky.social, founder of Challenge Works and the $10M #LongitudePrizeOnALS, joined the Live Life in Motion podcast to share his personal journey with #ALS. See below and listen here: Apple Podcasts: bit.ly/46YpSVZ Spotify: bit.ly/4f3herm

238. Hope in Motion: Tris Dyson’s Mission to Defeat Motor Neurone Disease

Podcast Episode · Live Life in Motion · 07/23/2025 · 56m

bit.ly

“MND is one of the most scientifically and biologically challenging diseases to tackle. That said, no mountain is insurmountable…” Dr. Mike Rogers (@mndassoc.bsky.social) shares why the #LongitudePrizeOnALS is key to creating new opportunities for #ALS & #MND 📰 longevity.technology/news/climbin...

Climbing the ALS mountain

Mike Rogers, MND Association Director of Research and Innovation, looks at how data and AI could unlock new treatments.

longevity.technology

📢 We’ll be at #ISMBECCB2025 in Liverpool! 🧠 Join the Longitude Prize on ALS team at Booth 23 & don’t miss our Tech Talk on the 22nd of July. 🔗Learn more: bit.ly/4kAPpIc